Editorial (Hot Topic :Randomized Clinical Trials in Inflammatory Bowel Disease)

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|7|4|255-255

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.7, Iss.4, 2012-11, pp. : 255-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: [Hot Topic: Therapeutic Antioxidants for Neurodegenerative Disease]

By  

Recent Patents on CNS Drug Discovery, Vol. 7, Iss. 3, 2012-12 ,pp. : 183-183

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 689-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: vedolizumab as a treatment and cause of extra‐intestinal manifestations of inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 535-536

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 494-495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical significance of the glucose breath test in patients with inflammatory bowel disease

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 990-994

John Wiley & Sons Inc

Access to resources Recommend Favorite